Literature DB >> 33737707

The effects of myelin on macrophage activation are phenotypic specific via cPLA2 in the context of spinal cord injury inflammation.

Timothy J Kopper1, Bei Zhang1, William M Bailey1, Kara E Bethel1, John C Gensel2.   

Abstract

Spinal cord injury (SCI) produces chronic, pro-inflammatory macrophage activation that impairs recovery. The mechanisms driving this chronic inflammation are not well understood. Here, we detail the effects of myelin debris on macrophage physiology and demonstrate a novel, activation state-dependent role for cytosolic phospholipase-A2 (cPLA2) in myelin-mediated potentiation of pro-inflammatory macrophage activation. We hypothesized that cPLA2 and myelin debris are key mediators of persistent pro-inflammatory macrophage responses after SCI. To test this, we examined spinal cord tissue 28-days after thoracic contusion SCI in 3-month-old female mice and observed both cPLA2 activation and intracellular accumulation of lipid-rich myelin debris in macrophages. In vitro, we utilized bone marrow-derived macrophages to determine myelin's effects across a spectrum of activation states. We observed phenotype-specific responses with myelin potentiating only pro-inflammatory (LPS + INF-γ; M1) macrophage activation, whereas myelin did not induce pro-inflammatory responses in unstimulated or anti-inflammatory (IL-4; M2) macrophages. Specifically, myelin increased levels of pro-inflammatory cytokines, reactive oxygen species, and nitric oxide production in M1 macrophages as well as M1-mediated neurotoxicity. PACOCF3 (cPLA2 inhibitor) blocked myelin's detrimental effects. Collectively, we provide novel spatiotemporal evidence that myelin and cPLA2 play an important role in the pathophysiology of SCI inflammation and the phenotype-specific response to myelin implicate diverse roles of myelin in neuroinflammatory conditions.

Entities:  

Year:  2021        PMID: 33737707      PMCID: PMC7973514          DOI: 10.1038/s41598-021-85863-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

1.  Activation of mitogen-activated protein kinase and cytosolic phospholipase A2 by hydrogen peroxide in fibroblasts.

Authors:  G S van Rossum; R de Wit; G Bunt; A J Verkleij; H van den Bosch; J A Post; J Boonstra
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 2.  Why is Wallerian degeneration in the CNS so slow?

Authors:  Mauricio E Vargas; Ben A Barres
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

3.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

Review 4.  Properties and regulation of cytosolic phospholipase A2.

Authors:  C C Leslie
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

5.  Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris.

Authors:  Xi Wang; Kai Cao; Xin Sun; Yongxiong Chen; Zhaoxia Duan; Li Sun; Lei Guo; Paul Bai; Dongming Sun; Jianqing Fan; Xijing He; Wise Young; Yi Ren
Journal:  Glia       Date:  2014-11-28       Impact factor: 7.452

6.  Lipid alterations following impact spinal cord injury in the rat.

Authors:  E J Murphy; D Behrmann; C M Bates; L A Horrocks
Journal:  Mol Chem Neuropathol       Date:  1994-09

7.  Characterization and modeling of monocyte-derived macrophages after spinal cord injury.

Authors:  Erin E Longbrake; Wenmin Lai; Daniel P Ankeny; Phillip G Popovich
Journal:  J Neurochem       Date:  2007-08       Impact factor: 5.372

8.  Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.

Authors:  Bei Zhang; Timothy J Kopper; Xiaodong Liu; Zheng Cui; Steven G Van Lanen; John C Gensel
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

9.  Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury.

Authors:  Nai-Kui Liu; Ling-Xiao Deng; Yi Ping Zhang; Qing-Bo Lu; Xiao-Fei Wang; Jian-Guo Hu; Eddie Oakes; Joseph V Bonventre; Christopher B Shields; Xiao-Ming Xu
Journal:  Ann Neurol       Date:  2014-04-02       Impact factor: 10.422

10.  Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Timothy J Kopper; Michael B Orr; David J Feola; John C Gensel
Journal:  J Neuroinflammation       Date:  2015-11-24       Impact factor: 8.322

View more
  4 in total

1.  Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury.

Authors:  Christine B Ryan; James S Choi; Hassan Al-Ali; Jae K Lee
Journal:  Neurobiol Dis       Date:  2021-12-31       Impact factor: 5.996

Review 2.  Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma.

Authors:  Hao-Jie Zhang; Yi-Tuo Chen; Xin-Li Hu; Wan-Ta Cai; Xiang-Yang Wang; Wen-Fei Ni; Kai-Liang Zhou
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

3.  Autologous Platelet-Rich Growth Factor Reduces M1 Macrophages and Modulates Inflammatory Microenvironments to Promote Sciatic Nerve Regeneration.

Authors:  Anjali Yadav; Thamil Selvee Ramasamy; Sheng-Che Lin; Szu-Han Chen; Jean Lu; Ya-Hsin Liu; Fu-I Lu; Yuan-Yu Hsueh; Shau-Ping Lin; Chia-Ching Wu
Journal:  Biomedicines       Date:  2022-08-17

Review 4.  Clickable Biomaterials for Modulating Neuroinflammation.

Authors:  Chase Cornelison; Sherly Fadel
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.